NEW YORK, Jan. 2, 2026 /PRNewswire/ -- Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved medical needs, today announced the filing of two U.S. provisional patent applications that significantly expand the Company's...
Hence then, the article about hoth therapeutics expands oncology pipeline with dual patent filings establishing novel oncology dermatology ip platform was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform )
Also on site :
- ‘Big Little Lies’ Author Teases Sequel Book, ‘Big Little Truths,’ And Season 3 Plot: “A Time Jump Always Made Sense To Me”
- ‘The Pitt’ Star Lucas Iverson Breaks Down Ogilvie’s Brutal Wake-Up Call: 'He’s Being Obliterated' (Exclusive)
- Super Micro Computer Issues Statement on Action by U.S. Attorney's Office